|
1
|
Forouzanfar MH, Foreman KJ, Delossantos
AM, et al: Breast and cervical cancer in 187 countries between 1980
and 2010: a systematic analysis. Lancet. 378:1461–1484. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Woodman CB, Collins SI and Young LS: The
natural history of cervical HPV infection: unresolved issues. Nat
Rev Cancer. 7:11–22. 2007. View
Article : Google Scholar
|
|
3
|
Jensen KE, Schmiedel S, Frederiksen K, et
al: Risk for cervical intraepithelial neoplasia grade 3 or worse in
relation to smoking among women with persistent human
papillomavirus infection. Cancer Epidemiol Biomarkers Prev.
21:1949–1955. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Werness BA, Levine AJ and Howley PM:
Association of human papillomavirus types 16 and 18 E6 proteins
with p53. Science. 248:76–79. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dyson N, Howley PM, Münger K and Harlow E:
The human papilloma virus-16 E7 oncoprotein is able to bind to the
retinoblastoma gene product. Science. 243:934–937. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Whiteside MA, Siegel EM and Unger ER:
Human papillomavirus and molecular considerations for cancer risk.
Cancer. 113(10 Suppl): 2981–2994. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Feinberg AP and Vogelstein B:
Hypomethylation distinguishes genes of some human cancers from
their normal counterparts. Nature. 301:89–92. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herman JG, Merlo A, Mao L, et al:
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated
with aberrant DNA methylation in all common human cancers. Cancer
Res. 55:4525–4530. 1995.PubMed/NCBI
|
|
10
|
Silva TD, Vidigal VM, Felipe AV, et al:
DNA methylation as an epigenetic biomarker in colorectal cancer.
Oncol Lett. 6:1687–1692. 2013.PubMed/NCBI
|
|
11
|
Jeong DH, Youm MY, Kim YN, et al: Promoter
methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical
cancer: correlation with clinicopathologic characteristics. Int J
Gynecol Cancer. 16:1234–1240. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Neyaz MK, Kumar RS, Hussain S, et al:
Effect of aberrant promoter methylation of FHIT and RASSF1A genes
on susceptibility to cervical cancer in a North Indian population.
Biomarkers. 13:597–606. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lendvai A, Johannes F, Grimm C, et al:
Genome-wide methylation profiling identifies hypermethylated
biomarkers in high-grade cervical intraepithelial neoplasia.
Epigenetics. 7:1268–1278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun Z, Asmann YW, Kalari KR, et al:
Integrated analysis of gene expression, CpG island methylation, and
gene copy number in breast cancer cells by deep sequencing. PLoS
One. 6:e174902011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li M, Balch C, Montgomery JS, et al:
Integrated analysis of DNA methylation and gene expression reveals
specific signaling pathways associated with platinum resistance in
ovarian cancer. BMC Med Genomics. 2:342009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Irizarry RA, Ladd-Acosta C, Carvalho B, et
al: Comprehensive high-throughput arrays for relative methylation
(CHARM). Genome Res. 18:780–790. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Agarwal SM, Raghav D, Singh H and Raghava
GP: CCDB: a curated database of genes involved in cervix cancer.
Nucleic Acids Res. 39:D975–979. 2011. View Article : Google Scholar :
|
|
18
|
Shin G, Kang TW, Yang S, et al: GENT: gene
expression database of normal and tumor tissues. Cancer Inform.
10:149–157. 2011.PubMed/NCBI
|
|
19
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang da W, Sherman BT, Tan Q, et al: The
DAVID Gene functional classification tool: a novel biological
module-centric algorithm to functionally analyze large gene lists.
Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim JM, Sohn HY, Yoon SY, et al:
Identification of gastric cancer-related genes using a cDNA
microarray containing novel expressed sequence tags expressed in
gastric cancer cells. Clin Cancer Res. 11:473–482. 2005.PubMed/NCBI
|
|
22
|
Li LC and Dahiya R: MethPrimer: designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chao A, Wang TH, Lee YS, et al: Molecular
characterization of adenocarcinoma and squamous carcinoma of the
uterine cervix using microarray analysis of gene expression. Int J
Cancer. 119:91–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song JY, Lee JK, Lee NW, et al: Microarray
analysis of normal cervix, carcinoma in situ, and invasive cervical
cancer: identification of candidate genes in pathogenesis of
invasion in cervical cancer. Int J Gynecol Cancer. 18:1051–1059.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kavanagh E, Tsapara A, Matter K and Balda
MS: Tight junctions and the regulation of epithelial cell
proliferation and gene expression. Tight Junctions. Springer; pp.
101–115. 2006, View Article : Google Scholar
|
|
26
|
Togami S, Nomoto M, Higashi M, et al:
Expression of mucin antigens (MUC1 and MUC16) as a prognostic
factor for mucinous adenocarcinoma of the uterine cervix. J Obstet
Gynaecol Res. 36:588–597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Munro EG, Jain M, Oliva E, et al:
Upregulation of MUC4 in cervical squamous cell carcinoma:
pathologic significance. Int J Gynecol Pathol. 28:127–133. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shames DS, Girard L, Gao B, et al: A
genome-wide screen for promoter methylation in lung cancer
identifies novel methylation markers for multiple malignancies.
PLoS Med. 3:e4862006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang W, Yan W, You G, et al: Genome-wide
DNA methylation profiling identifies ALDH1A3 promoter methylation
as a prognostic predictor in G-CIMP-primary glioblastoma. Cancer
Lett. 328:120–125. 2013. View Article : Google Scholar
|
|
30
|
Wong YF, Cheung TH, Tsao GS, et al:
Genome-wide gene expression profiling of cervical cancer in Hong
Kong women by oligonucleotide microarray. Int J Cancer.
118:2461–2469. 2006. View Article : Google Scholar
|
|
31
|
Bonazzi VF, Irwin D and Hayward NK:
Identification of candidate tumor suppressor genes inactivated by
promoter methylation in melanoma. Genes Chromosomes Cancer.
48:10–21. 2009. View Article : Google Scholar
|
|
32
|
Kim JH, Dhanasekaran SM, Prensner JR, et
al: Deep sequencing reveals distinct patterns of DNA methylation in
prostate cancer. Genome Res. 21:1028–1041. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang C, Li N, Liu X, Zheng Y and Cao X: A
novel endogenous human CaMKII inhibitory protein suppresses tumor
growth by inducing cell cycle arrest via p27 stabilization. J Biol
Chem. 283:11565–11574. 2008. View Article : Google Scholar : PubMed/NCBI
|
